These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24870739)

  • 1. Molecular markers for patients with thymic malignancies: not feasible at present?
    Avci N; Cecener G; Deligonul A; Erturk E; Tunca B; Egeli U; Tezcan G; Akyildiz EU; Bayram AS; Gebitekin C; Kurt E; Evrensel T
    Asian Pac J Cancer Prev; 2014; 15(8):3457-60. PubMed ID: 24870739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Kras gene mutation and copy number in thymic carcinomas and thymomas.
    Sasaki H; Yano M; Fujii Y
    J Thorac Oncol; 2010 Oct; 5(10):1715-6. PubMed ID: 20871271
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
    Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
    Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
    Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
    Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.
    Mimae T; Tsuta K; Kondo T; Nitta H; Grogan TM; Okada M; Asamura H; Tsuda H
    Ann Oncol; 2012 Dec; 23(12):3129-3137. PubMed ID: 22700994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3.
    Sakane T; Murase T; Okuda K; Saida K; Masaki A; Yamada T; Saito Y; Nakanishi R; Inagaki H
    Histopathology; 2019 Nov; 75(5):755-766. PubMed ID: 31179560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
    Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ
    Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.
    Berardi R; Brunelli A; Pagliaretta S; Paolucci V; Conti A; Goteri G; Refai M; Pompili C; Marcantognini G; Morgese F; Ballatore Z; Savini A; De Lisa M; Caramanti M; Santoni M; Zizzi A; Piva F; Mazzanti P; Onofri A; Sabbatini A; Scarpelli M; Cascinu S
    Oncotarget; 2015 Aug; 6(22):19305-15. PubMed ID: 26254278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.
    Monaco SE; Nikiforova MN; Cieply K; Teot LA; Khalbuss WE; Dacic S
    Hum Pathol; 2010 Jan; 41(1):94-102. PubMed ID: 19740513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population.
    Fakhruddin N; Mahfouz R; Farhat F; Tfayli A; Abdelkhalik R; Jabbour M; Yehia L; Mahfoud Z; Zaatari G
    Oncol Rep; 2014 Nov; 32(5):2223-9. PubMed ID: 25120214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis.
    Zeng H; Yang W; Xu B; Zou J; Su C; Zhong B; Zhu H; Chen Z
    BMC Cancer; 2020 Sep; 20(1):928. PubMed ID: 32993581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas.
    Kotoula V; Sozopoulos E; Litsiou H; Fanourakis G; Koletsa T; Voutsinas G; Tseleni-Balafouta S; Mitsiades CS; Wellmann A; Mitsiades N
    Endocr Relat Cancer; 2009 Jun; 16(2):565-72. PubMed ID: 19190079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy-relevant mutations of receptor tyrosine kinases in malignant thymomas and thymic carcinomas: a therapeutic perspective].
    Ströbel P; Knop S; Einsele H; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 2007; 91():177-86. PubMed ID: 18314613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic tumors: relevant molecular data in the clinic.
    Girard N
    J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S291-5. PubMed ID: 20859122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
    Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
    Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas.
    Hsieh MS; Kao HL; Huang WC; Wang SY; Lin SY; Chu PY; Pan CC; Chou TY; Ho HL; Yeh YC
    Mod Pathol; 2023 Feb; 36(2):100008. PubMed ID: 36853782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.
    Marotti JD; Schwab MC; McNulty NJ; Rigas JR; DeLong PA; Memoli VA; Tsongalis GJ; Padmanabhan V
    Diagn Cytopathol; 2013 Jan; 41(1):15-21. PubMed ID: 21681971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.